Home
>
References
>
2016
>
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib Plus Ipilimumab.
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib Plus Ipilimumab.
D'Angelo SP, Shoushtari AN, Keohan ML, Dickson MA, Gounder MM, Chi P, Loo JK, Gaffney L, Schneider L, Patel Z, Erinjeri JP, Bluth M, Sjoberg A, Streicher H, Takebe N, Qin LX, Antonescu CR, DeMatteo RP, Carvajal RD, Tap WD.
|
Journal
|
|
Clin Cancer Res.
|
|
Species
|
|
|
|
Analytes Measured
|
|
|
|
Matrix Tested
|
|
|
|
Year
|
|
2016
|
|
Volume
|
|
Journal Volume
|
|
Page Numbers
|
|
Journal Page Number(s)
|
|
Application
|
|
|
Abstract
View Publications
Browse Our Products
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters